SEPTISOL Drug Patent Profile
✉ Email this page to a colleague
When do Septisol patents expire, and when can generic versions of Septisol launch?
Septisol is a drug marketed by Vestal Labs and is included in two NDAs.
The generic ingredient in SEPTISOL is hexachlorophene. There are seven drug master file entries for this compound. Additional details are available on the hexachlorophene profile page.
Summary for SEPTISOL
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 80 |
Patent Applications: | 3,265 |
Formulation / Manufacturing: | see details |
DailyMed Link: | SEPTISOL at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for SEPTISOL
US Patents and Regulatory Information for SEPTISOL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Vestal Labs | SEPTISOL | hexachlorophene | AEROSOL;TOPICAL | 017424-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Vestal Labs | SEPTISOL | hexachlorophene | SOLUTION;TOPICAL | 017423-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |